维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Konstan MW"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	IV-treated pul- monary exacerbations in the prior year:An important Inde- pendent risk factor for future pulmonary exacerbation in cystic fibrosis 显示文摘	Vandevanter DR Morris NJ Konstan MW	2015	J Cyst Fibros2015，53，15：	1
2	Effect of Ibuprofen on Neutrophil Migration in Vivo in Cystic Fibrosis and Healthy Subjects显示文摘	Konstan MW Krenicky JE Finney MR	2003	The Journal of Pharmacology and Experimental Therapeutics2003，，3：	1
3	Cystic fibrosis显示文摘	Davis PB Drumm M Konstan MW		0，，：	1
4	Phase Ⅱ studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection显示文摘	Clancy JP Dupont L Konstan MW	2013	Throax2013，68，9：	1
5	Current understanding of the inflammatory process in cystic fibrosis:onset and etiology显示文摘	Konstan MW Berger M	1997	Pediatr Pulmonol1997，24，2：	1
6	Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution显示文摘	Konstan MW Davis PB Wagener JS	2004	Hum Gene Ther2004，15，12：	1
7	Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis显示文摘	Moss RB Mistry SJ Konstan MW	2013	J Cyst Fibros2013，12，3：	1
8	Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation 显示文摘	Konstan MW Hilliard KA Norvell TM	1994	Am J Respir Crit Care Med1994，150，2：	1
9	Phase II studies of nebuhsed Arikace in CF patients with Pseudomonas aerugiuosa infection 显示文摘	GLANCY JP DUPONT L KONSTAN MW	2013	Thorax2013，68，9：	1
10	Elastin and collagen degradation products in urine of patients with cystic fibrosis显示文摘	Stone PJ Konstan MW Berger M	1995	Am J Respir Grit Care Med1995，152，1：	1
11	Current understanding of the inflammatory process in cystic fibrosis: onset and etiology 显示文摘	Konstan MW Berger M	1997	Pediatr Pulmonol1997，4，：	1
12	The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in palients with cystic fibrosis显示文摘	Blumer JL Saiman L Konstan MW	2005	Chest2005，128，4：	1
13	Safety,efficacy and convenience of tobramycin inhalation powder in cystic fibrosis pa- tients; The EAGER trial显示文摘	Konstan MW Flume PA Kappler M	2011	J Cyst Fibres2011，10，1：	1
14	Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis显示文摘	Konstan MW Stern RC Doershuk CF	1994	J Pediatr1994，124，5：	1
15	Clinical use of ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis显示文摘	Konstan MW Schluchter MD Xue W	2007	Am J Respir Crit Care Med2007，176，11：	1
16	Ibuprofen attenuates the imflammatory response to pseudomonas aeruginosa in a rat model of chronic pulmonary infection implications for antiintlammatory therapy in cystic fibrosis 显示文摘	Konstan MW Vargo KM Davis PB	1990	Am Rev Respir Dis1990，141，1：	1
17	Safety, efficacy and con- venience of tobramycin inhalation powder in cystic fibrosis pa- tients : The EAGER trial显示文摘	Konstan MW Flume PA Kappler M	2011	J Cyst Fibros2011，10，1：	1
18	Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection显示文摘	Clancy JP Dupont L Konstan MW	2013	Thorax2013，68，9：	1
19	Phase I/ studies of nebulised Afikace in CF patients with pseudomonas aeruginosa infection显示文摘	Clancy JP Dupont L Konstan MW	2013	Thorax2013，68，9：	1
20	Prolonged inflammatory response to acute pseudomonas challenge in interleukin-10 knockout mice 显示文摘	Chmiel JF Konstan MW Saadane A	2002	Am J Respir Crit Care Meal2002，165，11：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示